ATE312923T1 - Moraxella catarrhalis basb034 polypeptide und verwendungen davon - Google Patents

Moraxella catarrhalis basb034 polypeptide und verwendungen davon

Info

Publication number
ATE312923T1
ATE312923T1 AT99946171T AT99946171T ATE312923T1 AT E312923 T1 ATE312923 T1 AT E312923T1 AT 99946171 T AT99946171 T AT 99946171T AT 99946171 T AT99946171 T AT 99946171T AT E312923 T1 ATE312923 T1 AT E312923T1
Authority
AT
Austria
Prior art keywords
immunogenic fragments
basb034 polypeptides
polypeptides
moraxella catarrhalis
seq
Prior art date
Application number
AT99946171T
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE312923T1 publication Critical patent/ATE312923T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99946171T 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptide und verwendungen davon ATE312923T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9820002.5A GB9820002D0 (en) 1998-09-14 1998-09-14 Novel compounds
PCT/EP1999/006781 WO2000015802A1 (en) 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
ATE312923T1 true ATE312923T1 (de) 2005-12-15

Family

ID=10838841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99946171T ATE312923T1 (de) 1998-09-14 1999-09-14 Moraxella catarrhalis basb034 polypeptide und verwendungen davon

Country Status (21)

Country Link
US (2) US6600013B1 (de)
EP (1) EP1114160B1 (de)
JP (1) JP2002525057A (de)
KR (1) KR20010085794A (de)
CN (1) CN1198931C (de)
AT (1) ATE312923T1 (de)
AU (1) AU752667B2 (de)
BR (1) BR9914492A (de)
CA (1) CA2342398A1 (de)
CZ (1) CZ2001927A3 (de)
DE (1) DE69928947T2 (de)
ES (1) ES2253911T3 (de)
GB (1) GB9820002D0 (de)
HU (1) HUP0103945A3 (de)
IL (1) IL141996A0 (de)
NO (1) NO20011263L (de)
NZ (1) NZ510512A (de)
PL (1) PL347943A1 (de)
TR (1) TR200100741T2 (de)
WO (1) WO2000015802A1 (de)
ZA (1) ZA200102108B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812163D0 (en) 1998-06-05 1998-08-05 Smithkline Beecham Biolog Novel compounds
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CN1674933B (zh) 2002-08-02 2012-09-26 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
US7476509B2 (en) * 2002-11-14 2009-01-13 Adherex Technologies Inc. Compounds and methods for modulating functions of nonclassical cadherins
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69740108D1 (de) * 1996-12-20 2011-03-10 Univ Texas Moraxella catarrhalis antigene uspa1 und uspa2
US6673910B1 (en) 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
CA2378687A1 (en) * 1999-06-18 2000-12-28 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins

Also Published As

Publication number Publication date
ZA200102108B (en) 2002-10-23
JP2002525057A (ja) 2002-08-13
CA2342398A1 (en) 2000-03-23
BR9914492A (pt) 2001-06-26
US7432366B2 (en) 2008-10-07
CZ2001927A3 (cs) 2001-08-15
US20030180317A1 (en) 2003-09-25
US6600013B1 (en) 2003-07-29
HUP0103945A2 (hu) 2002-02-28
HUP0103945A3 (en) 2003-11-28
EP1114160A1 (de) 2001-07-11
PL347943A1 (en) 2002-04-22
IL141996A0 (en) 2002-03-10
NO20011263D0 (no) 2001-03-13
NO20011263L (no) 2001-04-30
CN1198931C (zh) 2005-04-27
ES2253911T3 (es) 2006-06-01
WO2000015802A1 (en) 2000-03-23
AU752667B2 (en) 2002-09-26
EP1114160B1 (de) 2005-12-14
KR20010085794A (ko) 2001-09-07
NZ510512A (en) 2002-10-25
CN1326509A (zh) 2001-12-12
GB9820002D0 (en) 1998-11-04
DE69928947T2 (de) 2006-06-29
TR200100741T2 (tr) 2001-09-21
AU5863299A (en) 2000-04-03
DE69928947D1 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
MX9702714A (es) Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral.
DE60039050D1 (de) Antigene meningokokken peptide
GB9911683D0 (en) Antigenic peptides
EP2316479A3 (de) Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten
ATE364083T1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
ATE488249T1 (de) Immunologisch bedeutende herpes-simplex-virus- antigene und verfahren für ihre verwendung
EP0733071A4 (de) Chaperonin - antagonisten
DE69928947D1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
AU5776799A (en) Modified hcv peptide vaccines
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
TW200716166A (en) Lawsonia intracellularis immunological proteins
DK0938329T3 (da) Immunogen TLP sammensætning
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
EP1372691A4 (de) Mucinpeptid mit immunstärkenden eigenschaften
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
RU2003130226A (ru) Применение белка uk114 или его фрагментов для лечения и предупреждения эндотоксического шока
WO2000026240A3 (en) Streptococcal alpha2m-binding protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties